CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy · Terms of Service · Privacy FAQ

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
ASP Isotopes›
Analysis
ASP Isotopes

ASP Isotopes

ASP Isotopes enriches stable isotopes for medical, semiconductor, and nuclear energy customers with Aerodynamic Separation Process and Quantum Enrichment technologies.

Operating headquarters
Dallas, TX, US🇺🇸
Founded
2021
Loading
Overview
Relationships
Analysis
Compare
Employees
News
Library

Contents

  1. 01Products & Services
  2. 02Market Outlook
  3. 03Competitive Strengths
  1. 01Products & Services
  2. 02Market Outlook
  3. 03Competitive Strengths

Product Overview

ASP Isotopes enriches stable isotopes using its proprietary Aerodynamic Separation Process and Quantum Enrichment technologies, operating enrichment facilities in Pretoria, South Africa. The company sells enriched isotopes and related materials into nuclear medicine, semiconductor, and nuclear energy supply chains.

Its commercial offer centers on supplying critical materials, including medical isotopes and highly enriched silicon-28, while subsidiary Quantum Leap Energy addresses the nuclear fuel market. The acquired subsidiary Renergen adds helium and liquefied natural gas production to the group's revenue base.

Market Outlook

ASP Isotopes targets three end markets for its enriched isotopes and related materials. In medical isotopes it is developing molybdenum-100, ytterbium-176, zinc-68, nickel-64, and carbon-14; in semiconductor materials it is advancing highly enriched silicon-28 produced from natural silane alongside depleted germanium-73; and through subsidiary Quantum Leap Energy it addresses nuclear fuels with HALEU, LEU+, and lithium-6 and lithium-7.

The company positions these markets around supply chain gaps in critical materials, with nuclear medicine demand supported by radiopharmaceutical growth and semiconductor demand tied to next-generation chip manufacturing. The Renergen acquisition adds helium and liquefied natural gas production serving industrial and technology customers.

Competitive Advantages

The Aerodynamic Separation Process is a stationary-wall centrifuge gaseous-diffusion process that uses proprietary flow directors to separate isotopes, and the Silicon-28 enrichment facility at Koedoespoort, Pretoria operates a 48-stage cascade. Quantum Enrichment applies precisely tuned laser-based isotope separation that exploits transition energies.

Together these technologies are designed to enable commercial-scale production of isotopes for nuclear medicine, semiconductor, and nuclear energy applications. They form the technical basis of a differentiated enrichment platform intended to strengthen supply chain access to critical materials.